Cancer environmental immunotherapy: starving tumor cell to death by targeting TGFB on immune cell

Cancer environmental immunotherapy: starving tumor cell to death by targeting TGFB on immune cell

The blockage of intersectional communication between tumor and its metabolic and immune microenvironment is now considered a promising solution in treating cancer. Tumors have been identified as a special type of “wounds” that do not heal. Recent studies demonstrate that the lack of the transforming...

Full description

Bibliographic Details
Main Authors:	Xing Huang, Gang Zhang
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-06-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/9/6/e002823.full

Similar Items

VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
by: Xing Huang, et al.
Published: (2020-06-01)

Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
by: Tianyu Tang, et al.
Published: (2021-02-01)

Cell Death in the Tumor Microenvironment: Implications for Cancer Immunotherapy
by: Varsha Gadiyar, et al.
Published: (2020-09-01)

Cancer Immunotherapies Targeting Tumor-Associated Regulatory T Cells
by: Ge X, et al.
Published: (2019-12-01)

Targeting Innate Immune Cells for Immunotherapy
by: Leandro J. Carreño, et al.
Published: (2017-01-01)

New Era of Regulatory T Cells in Tumor Immunity: Insights in Cancer Immunotherapy
by: Bor-Ching Sheu, et al.
Published: (2010-01-01)

Production and purification of TGFb-1 in CHO-Cells
by: Abdulkerim Estabraq, et al.
Published: (2011-12-01)

Immunology of Cell Death in Cancer Immunotherapy
by: Lorenzo Galluzzi, et al.
Published: (2021-05-01)

Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking
by: João eConniot, et al.
Published: (2014-11-01)

Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
by: Yan Dong, et al.
Published: (2021-04-01)

Targeting Natural Killer Cells for Tumor Immunotherapy
by: Cai Zhang, et al.
Published: (2020-02-01)

Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets
by: Hwei-Fang Tsai, et al.
Published: (2017-05-01)

Starved to Death? Nutrition in Asylums During the World Wars
by: Kristina Engwall
Published: (2006-08-01)

Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1
by: Jing Zhao, et al.
Published: (2020-04-01)

The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy
by: Yuxia Liu, et al.
Published: (2020-05-01)

T Cell Dysfunction in Cancer Immunity and Immunotherapy
by: Anliang Xia, et al.
Published: (2019-07-01)

Snail controls TGFB responsiveness and diferentiation of MS cells
by: Batlle Gómez, Raquel
Published: (2011)

Starve Cancer Cells of Glutamine: Break the Spell or Make a Hungry Monster?
by: Jie Jiang, et al.
Published: (2019-06-01)

Starved and asphyxiated: how can CD8+T cells within a tumor microenvironment prevent tumor progression
by: Ying eZhang, et al.
Published: (2016-02-01)

Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy
by: Grégory Verdeil, et al.
Published: (2019-11-01)

Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?
by: Thijs A. van Schaik, et al.
Published: (2021-06-01)

miR-599 Inhibits Vascular Smooth Muscle Cells Proliferation and Migration by Targeting TGFB2.
by: Baodong Xie, et al.
Published: (2015-01-01)

Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy
by: Michael F. Coleman, et al.
Published: (2020-04-01)

The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
by: Vincenzo Salemme, et al.
Published: (2021-03-01)

Immune checkpoint‑targeted cancer immunotherapies
by: Julian Swatler, et al.
Published: (2016-01-01)

Immune checkpoint‑targeted cancer immunotherapies
by: Julian Swatler, et al.
Published: (2016-01-01)

The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
by: Kevin Leone, et al.
Published: (2018-08-01)

Starved society?
by: Damle S
Published: (2008-01-01)

Starving by Numbers
by: Mangham, Andrew S.
Published: (2015-12-01)

The role of Activin B and TGFb1 in regulating endometrial cancer cell adhesion and migration
by: Xiong, Siyuan
Published: (2016)

Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors
by: Qi J, et al.
Published: (2021-02-01)

Starved epithelial cells uptake extracellular matrix for survival
by: Taru Muranen, et al.
Published: (2017-01-01)

Regulation of cell death in cancer – possible implications for immunotherapy
by: Simone eFulda
Published: (2013-02-01)

Regulating immune memory and reversing tumor thermotolerance through a step-by-step starving-photothermal therapy
by: Lihua Luo, et al.
Published: (2021-09-01)

Corrigendum: Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1
Published: (2021-03-01)

Creatine in T Cell Antitumor Immunity and Cancer Immunotherapy
by: Bo Li, et al.
Published: (2021-05-01)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
by: Kyle K. Payne, et al.
Published: (2012-01-01)

Tumor immune response and immunotherapy in gastric cancer
by: Yoonjin Kwak, et al.
Published: (2020-01-01)

212 CLEC-1 is a novel myeloid immune checkpoint for cancer immunotherapy limiting tumor cells phagocytosis and synergizing with tumor-targeted antibodies
by: Vanessa Gauttier, et al.
Published: (2020-11-01)

Tumor-Derived Extracellular Vesicles: Their Role in Immune Cells and Immunotherapy
by: Li Q, et al.
Published: (2021-08-01)

Cannot write session to /tmp/vufind_sessions/sess_sgnvppvvlviu227ni9f598jveo